June 2, 2023

The Mifepristone Case and the Legitimacy of the FDA

Key Points

Key points are not available for this paper at this time.

Abstract

This Viewpoint discusses a recent federal court decision that invaliated the Food and Drug Administration’s (FDA) approval of mifepristone, a drug used to end pregnancies and manage miscarriage when used with misoprostol, and how that decision challenges the legitimacy and independence of the FDA.

AIに質問

Bookmark

Cite This Study

Abbe R. Gluck (Fri,) studied this question.

synapsesocial.com/papers/6a1035f3fa36b6e053fd5bdb https://doi.org/https://doi.org/10.1001/jama.2023.8712

Also Consider

Synapse has enriched one closely related paper. Consider it for comparative context:

1Information about Mifepristone for medical termination of pregnancy through 10 weeks gestation2023 · 2 citations

AIに質問

Bookmark